Celltrion Inc
KRX:068270
Celltrion Inc
Cost of Revenue
Celltrion Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Celltrion Inc
KRX:068270
|
Cost of Revenue
-₩1.2T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-32%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Cost of Revenue
-₩227.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
Green Cross Corp
KRX:006280
|
Cost of Revenue
-₩1.2T
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Cost of Revenue
-₩76.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Cost of Revenue
-₩78.7B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Cost of Revenue
-₩65.3B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Celltrion Inc's Cost of Revenue?
Cost of Revenue
-1.2T
KRW
Based on the financial report for Mar 31, 2024, Celltrion Inc's Cost of Revenue amounts to -1.2T KRW.
What is Celltrion Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-32%
Over the last year, the Cost of Revenue growth was 23%. The average annual Cost of Revenue growth rates for Celltrion Inc have been -15% over the past three years , -23% over the past five years , and -32% over the past ten years .